NCT06203691

Brief Summary

The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

February 21, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

January 2, 2024

Last Update Submit

March 26, 2024

Conditions

Keywords

ArthroplastiesKnee & Hip ReplacementDietary Supplements

Outcome Measures

Primary Outcomes (3)

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a questionnaire that measures the impact of osteoarthritis on pain, stiffness, and physical function in the hip or knee joints. It is a self-administered tool that consists of 24 items, each rated on a scale of 0 to 4, with higher scores indicating worse symptoms. The WOMAC is widely used in clinical trials and research studies to evaluate the effectiveness of treatments and interventions for osteoarthritis.

    30+ days prior to surgery, 14-days after surgery, 28-30 days after surgery

  • Timed Up & Go (TUG)

    The Timed Up and Go test or TUG test is used to help evaluate mobility. It is a simple test that measures how quickly one can stand up, walk 10 feet, turn around, walk back, and sit down. It is often done to assess mobility in older adults or predict their risk of falls.

    30+ days prior to surgery, 14-days after surgery, 28-30 days after surgery

  • Grip Strength using a Jamar Hydraulic Hand Dynamometerer

    Grip Strength is a measure of the maximum force or tension generated by one's forearm muscles when gripping an object. A Jamar Hydraulic Hand Dynamometer is a device that can measure this force in pounds or kilograms. It is commonly used by physical therapists, occupational therapists, and hand surgeons to assess grip strength and monitor recovery or rehabilitation.

    30+ days prior to surgery, 14-days after surgery, 28-30 days after surgery

Study Arms (2)

Supplement Group

EXPERIMENTAL

50 of the 100 participants will be given supplements (Prepare \& Recover) for pre \& post operation.

Dietary Supplement: Supplementation with Nirvana Super Pro Liquid Supplements

Non-Supplement Group

PLACEBO COMPARATOR

No supplements will be given to the non-supplement group.

Dietary Supplement: Non-Supplementation Group

Interventions

Intervention will measure strength pre \& post operatively. Intervention group will receive liquid supplements (3oz daily shots) pre (Prepare) and Post (Recover) operatively.

Supplement Group
Non-Supplementation GroupDIETARY_SUPPLEMENT

Intervention will measure strength pre \& post operatively. Intervention group will not receive liquid supplements.

Also known as: Control Group
Non-Supplement Group

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects will be enrolled into the study.
  • Age ≥45-80 years.
  • Free of liver and kidney diseases, and with no evidence of uncontrolled hypertension.
  • Does not have a chronic disease that affects calcium or bone metabolism (i.e., asthma with chronic use of high dose steroids, inflammatory bowel disease, Crohn's disease, primary hyperparathyroidism, seizure disorder with use of phenobarbital, etc.).
  • Not classified as morbidly obese (body mass index (BMI) \>43 kg/m2).
  • Six weeks since major surgery (three weeks since minor surgery).
  • Total joint replacement is not a revision of previous joint replacement.
  • Willing to consume dietary supplements for the study period.
  • Individuals diagnosed with osteoporosis, or a bone density \>2.0 standard deviations below the mean, will not be enrolled in the study.
  • No other serious medical illness.
  • Physicians have placed no restriction on physical exercise.
  • Patient is scheduled for a total knee or hip replacement and agrees to consume the 28-day pre-operative regime.

You may not qualify if:

  • Evidence of liver and kidney diseases, uncontrolled hypertension, or Type I or II diabetes mellitus requiring insulin for glucose control.
  • The presence of a chronic disease that affects calcium or bone metabolism (i.e., asthma with chronic use of high dose steroids, inflammatory bowel disease, Crohn's disease, primary hyperparathyroidism, seizure disorder with use of phenobarbital, etc.).
  • Classified as morbidly obese (body mass index (BMI) \>43 kg/m2).
  • Less than six weeks since major surgery or three weeks since minor surgery.
  • Surgery is a revision of a previous total joint replacement.
  • Not willing to consume nutritional supplements for the study period.
  • Individuals diagnosed with osteoporosis, or a bone density \>2.0 standard deviations below the mean, will not be enrolled in the study.
  • Other serious medical illness, which the subject's doctor or medical review team has decided affects the subject's ability to participate in the study. For example, pathological hip fracture or cancer disease in active phase or undergoing treatment (radiotherapy or chemotherapy).
  • History of blood clots and/or the use of blood thinning medications
  • Subjects on high dose vitamin D therapies (i.e., 50,000 IU vitamin D).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Orthopedics Center

Altoona, Pennsylvania, 16602, United States

RECRUITING

Related Publications (6)

  • Bear DE, Langan A, Dimidi E, Wandrag L, Harridge SDR, Hart N, Connolly B, Whelan K. beta-Hydroxy-beta-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis. Am J Clin Nutr. 2019 Apr 1;109(4):1119-1132. doi: 10.1093/ajcn/nqy373.

    PMID: 30982854BACKGROUND
  • Hiemstra LA, Gofton WT, Kriellaars DJ. Hip strength following hamstring tendon anterior cruciate ligament reconstruction. Clin J Sport Med. 2005 May;15(3):180-2. doi: 10.1097/01.jsm.0000157795.93004.ea.

    PMID: 15867563BACKGROUND
  • Nishizaki K, Ikegami H, Tanaka Y, Imai R, Matsumura H. Effects of supplementation with a combination of beta-hydroxy-beta-methyl butyrate, L-arginine, and L-glutamine on postoperative recovery of quadriceps muscle strength after total knee arthroplasty. Asia Pac J Clin Nutr. 2015;24(3):412-20. doi: 10.6133/apjcn.2015.24.3.01.

    PMID: 26420181BACKGROUND
  • Silva AM, Shen W, Heo M, Gallagher D, Wang Z, Sardinha LB, Heymsfield SB. Ethnicity-related skeletal muscle differences across the lifespan. Am J Hum Biol. 2010 Jan-Feb;22(1):76-82. doi: 10.1002/ajhb.20956.

    PMID: 19533617BACKGROUND
  • Wilkinson DJ, Hossain T, Hill DS, Phillips BE, Crossland H, Williams J, Loughna P, Churchward-Venne TA, Breen L, Phillips SM, Etheridge T, Rathmacher JA, Smith K, Szewczyk NJ, Atherton PJ. Effects of leucine and its metabolite beta-hydroxy-beta-methylbutyrate on human skeletal muscle protein metabolism. J Physiol. 2013 Jun 1;591(11):2911-23. doi: 10.1113/jphysiol.2013.253203. Epub 2013 Apr 3.

    PMID: 23551944BACKGROUND
  • Wu H, Xia Y, Jiang J, Du H, Guo X, Liu X, Li C, Huang G, Niu K. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2015 Sep-Oct;61(2):168-75. doi: 10.1016/j.archger.2015.06.020. Epub 2015 Jul 3.

    PMID: 26169182BACKGROUND

MeSH Terms

Interventions

Dietary SupplementsControl Groups

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Candice St. Pierre, Ph.D.

    Nirvana Water Sciences Corp

    STUDY CHAIR

Central Study Contacts

Candice St. Pierre, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Participants will be assigned a number and by the care provider staff prior to providing collecting data.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: One group will receive the supplements. The control group will not receive the supplements. All participants will undergo strength test - pre and post operatively.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 12, 2024

Study Start

February 21, 2024

Primary Completion

June 30, 2024

Study Completion

August 30, 2024

Last Updated

March 27, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Masked IDP data will be shared with researchers for statistical analysis and conclusions.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available for 2 months for statistical analysis.
Access Criteria
Data will be securely shared and only masked participant data will be shared with researchers.

Locations